The Trump administration has introduced a new policy that complicates health care access for male veterans diagnosed with breast cancer. This change, detailed in a Department of Veterans Affairs (VA) memo, does not rely on new scientific findings but instead references a presidential order from Trum
In Europe, the number of people living with cancer is growing by 3. 5% each year since 2010. Out of all these survivors, 38% will live a decade or more after their diagnosis. Colorectal cancer (CRC) is the second most common cancer among survivors, and many of them will be over 75 years old, needing
Breast cancer is a big deal, especially for women. As people live longer, more older adults are facing this disease. New treatments are being developed all the time. These include targeted therapies and new combinations of drugs. This is great news for many patients. But there's a catch. Older adult
Prostate cancer is a big deal. It's the most common cancer in men, both in the U. S. and worldwide. And it's getting more common, especially the serious kind. But what makes some cases more aggressive than others? That's a tough question. Some research suggests that heart and metabolic health might
In the world of cancer treatment, new methods are always being explored. One such method is HIPEC, which involves delivering heated chemotherapy directly into the abdomen during surgery. But with this treatment, a big question arises: which chemotherapy drug is safer when used in high doses? Two dr
Colon cancer is a serious disease that takes many lives. Scientists have found that a protein called B7-H4 is more active in colon cancer cells than in healthy cells. This protein helps cancer cells grow. So far, no medicines have been made to target B7-H4 in colon cancer treatment. Researchers set
In Japan, doctors have a tough job. They must navigate between treatments covered by public health insurance and costly private options that lack solid evidence. These expensive treatments, referred to as "X" in a recent study, have sparked a debate among oncologists. Over 6, 000 oncologists were s
The COVID-19 mRNA vaccines, which played a big role in saving lives during the pandemic, might also have a surprising benefit: helping the immune system fight cancer. This idea came from a study that looked at how these vaccines affect patients with certain types of cancer. The study focused on pat
Recent findings suggest that mRNA COVID-19 vaccines, like those from Pfizer and Moderna, could offer a surprising advantage for advanced cancer patients. The research, published in Nature, indicates that these vaccines might enhance the effectiveness of cancer immunotherapy. The study focused on pa
Recent data shows a significant drop in the number of young adults identifying as transgender. In just two years, the numbers have nearly halved. This shift raises questions about societal influences, personal journeys, and the broader context of gender identity. Meanwhile, medical science is makin
